Drugs / PRP Protocol B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05824806 Comparator | Aug 2024 → Aug 2025 overdue | osteoarthritis, knee | National Institute of Traumatology and Orthopaedics | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP Protocol B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05824806 ↗ |
| Known as | PRP B | “platelet-rich plasma (PRP B)” NCT05824806 ↗ |
| Modality | Other / unclassified | “PRP is an autologous blood product” NCT05824806 ↗ |
| Route | Other | “intra-articular injection of platelet-rich plasma (PRP B)” NCT05824806 ↗ |